Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.

Jonathan FintziTyler BonnettPablo TebasMahomed-Yunus MoosaCorri B LevineHana M El SahlySusan L F McLellanConstance A BensonChristina A RostadAnuradha GanesanNikhil HuprikarMaria G FrankRichard A MularskiRobert L AtmarPauline K ParkWilliam R ShortJohn H BeigelAneesh K MehtaDaniel A Sweeney

Published in: Open forum infectious diseases (2022)

Compared with RMT, BCT reduces the clinical burden and utilization of intensive respiratory therapies for patients requiring low-flow oxygen or noninvasive positive-pressure ventilation compared with RMT and may thereby improve care for this patient population.

Keyphrases

sars cov
end stage renal disease
healthcare
coronavirus disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
combination therapy
quality improvement
extracorporeal membrane oxygenation
smoking cessation
health insurance